UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000040539
Receipt number R000046274
Scientific Title Study for medical support using smart devise for IBD patients under the novel coronavirus prevalence.
Date of disclosure of the study information 2020/07/01
Last modified on 2020/11/26 09:07:46

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study for medical support using smart devise for IBD patients under the novel coronavirus prevalence.

Acronym

Medical support using IBD app

Scientific Title

Study for medical support using smart devise for IBD patients under the novel coronavirus prevalence.

Scientific Title:Acronym

Medical support using IBD app

Region

Japan


Condition

Condition

Inflammatory Bowel Disease

Classification by specialty

Gastroenterology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

It is difficult for the patients to come hospital under the novel coronavirus prevalence. We aim to evaluate the utility of smart device, which the patients are able to input their symptoms every day. Moreover, the doctors are also able to check clinical state of each IBD patients.

Basic objectives2

Others

Basic objectives -Others

benefit of smart device for the patients with IBD

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Utilization rate of smart device after 24 weeks

Key secondary outcomes

Clinical state of the patients


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

The patients with Ulcerative Colitis who attend our hospital.

Key exclusion criteria

under 19 years old

Target sample size

2000


Research contact person

Name of lead principal investigator

1st name Kiichiro
Middle name
Last name Tsuchiya

Organization

Tokyo Medical and Dental University

Division name

Gastroenterology and Hepatology

Zip code

113-8519

Address

1-5-45, Yushima, Bunkyo-ku, Tokyo

TEL

03-5803-5974

Email

kii.gast@tmd.ac.jp


Public contact

Name of contact person

1st name Kiichiro
Middle name
Last name Tsuchiya

Organization

Tokyo Medical and Dental University

Division name

Gastroenterology and Hepatology

Zip code

113-8519

Address

1-5-45, Yushima, Bunkyo-ku, Tokyo

TEL

03-5803-5974

Homepage URL


Email

kii.gast@tmd.ac.jp


Sponsor or person

Institute

Tokyo Medical and Dental University

Institute

Department

Personal name



Funding Source

Organization

Hitachi, Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Tokyo Medical and Dental University ethics committee

Address

1-5-45, Yushima, Bunkyo-ku, Tokyo

Tel

03-5803-5096

Email

info.bec@tmd.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 07 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2020 Year 05 Month 26 Day

Date of IRB

2020 Year 05 Month 26 Day

Anticipated trial start date

2020 Year 07 Month 01 Day

Last follow-up date

2025 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

None


Management information

Registered date

2020 Year 05 Month 27 Day

Last modified on

2020 Year 11 Month 26 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046274